Current and novel pharmacologic approaches in advanced heart failure.
Publication
, Journal Article
O'Connor, CM; Gattis, WA; Swedberg, K
Published in: Heart Lung
1999
Duke Scholars
Published In
Heart Lung
DOI
ISSN
0147-9563
Publication Date
1999
Volume
28
Issue
4
Start / End Page
227 / 242
Location
United States
Related Subject Headings
- Vasodilator Agents
- Nursing
- Humans
- Heart Failure
- Drug Therapy, Combination
- Diuretics
- Cardiovascular Agents
- Anticoagulants
- Anti-Arrhythmia Agents
- Adrenergic beta-Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M., Gattis, W. A., & Swedberg, K. (1999). Current and novel pharmacologic approaches in advanced heart failure. Heart Lung, 28(4), 227–242. https://doi.org/10.1016/s0147-9563(99)70069-5
O’Connor, C. M., W. A. Gattis, and K. Swedberg. “Current and novel pharmacologic approaches in advanced heart failure.” Heart Lung 28, no. 4 (1999): 227–42. https://doi.org/10.1016/s0147-9563(99)70069-5.
O’Connor CM, Gattis WA, Swedberg K. Current and novel pharmacologic approaches in advanced heart failure. Heart Lung. 1999;28(4):227–42.
O’Connor, C. M., et al. “Current and novel pharmacologic approaches in advanced heart failure.” Heart Lung, vol. 28, no. 4, 1999, pp. 227–42. Pubmed, doi:10.1016/s0147-9563(99)70069-5.
O’Connor CM, Gattis WA, Swedberg K. Current and novel pharmacologic approaches in advanced heart failure. Heart Lung. 1999;28(4):227–242.
Published In
Heart Lung
DOI
ISSN
0147-9563
Publication Date
1999
Volume
28
Issue
4
Start / End Page
227 / 242
Location
United States
Related Subject Headings
- Vasodilator Agents
- Nursing
- Humans
- Heart Failure
- Drug Therapy, Combination
- Diuretics
- Cardiovascular Agents
- Anticoagulants
- Anti-Arrhythmia Agents
- Adrenergic beta-Antagonists